Key result
HeartFusion achieves ~98% diagnostic accuracy for CVD across paired ECG-MRI cohorts.
Why the study?
Cardiovascular disease requires diagnostic models that integrate complementary electrophysiological and anatomical information while also representing ordered disease severity.
Does the HeartFusion cross-modality Transformer framework combining ECG and cardiac MRI accurately diagnose cardiovascular disease and assess ordered disease severity in pseudo-paired benchmark cohorts?
Does the HeartFusion cross-modality Transformer framework combining ECG and cardiac MRI accurately diagnose cardiovascular disease and assess ordered disease severity in pseudo-paired benchmark cohorts?
Answers are grounded in this paper and cite their sources.
HeartFusion demonstrates high diagnostic and severity-staging accuracy (>97% and >90%, respectively) by integrating ECG and cardiac MRI representations in pseudo-paired cohorts, though validation in real patient-matched cohorts is required before clinical use.
Cardiovascular disease (CVD) requires diagnostic models that can integrate complementary electrophysiological and anatomical information while also representing ordered disease severity. HeartFusion was developed as a mathematically informed cross-modality Transformer framework combining electrocardiogram (ECG) and cardiac magnetic resonance imaging (MRI). Wavelet-derived ECG time-frequency representations were encoded with Cardioformer, MRI structure was encoded with TransUNet, and modality-specific embeddings were aligned in a shared latent space using cosine-similarity-based cross-modal attention. A transformer classifier performed diagnostic prediction, while an ordinal regression head modeled four ordered severity stages. Three controlled pseudo-paired benchmark cohorts were constructed from PTB-XL with ACDC (CVD-I), MIMIC-IV-ECG with CMRxRecon (CVD-II), and PTB-XL/MIMIC-IV-ECG with OCMR/Cardiac Atlas Project data (CVD-III). Source observations were partitioned before pseudo-pair construction to prevent cross-partition leakage, and five matched random seeds were used for evaluation. HeartFusion achieved diagnostic accuracies of 97.73%, 98.23%, and 98.02%, with AUC values of 98.12%, 98.76%, and 98.39% on CVD-I, CVD-II, and CVD-III, respectively. Severity staging achieved ordinal accuracies above 90%, with the best Cohen's kappa of 0.839 and MAE of 0.340. These findings support phenotype-level multimodal representation learning, while validation on genuinely patient-matched ECG-MRI cohorts remains necessary before clinical deployment.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied Cardiovascular disease. HeartFusion cross-modality Transformer framework combining ECG and cardiac MRI was evaluated on Cardiovascular disease diagnostic accuracy and ordered severity staging. HeartFusion achieved CVD diagnostic accuracies of 97.73%-98.23% and severity staging accuracies >90% across three pseudo-paired ECG-MRI cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: